Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

When can cyclodextrins be considered for solubilization purposes?

Venkatramana M Rao1, Valentino J Stella

  • 1Department of Pharmaceutical Chemistry, The University of Kansas, 2095 Constant Avenue, Lawrence, Kansas 66047, USA.

Journal of Pharmaceutical Sciences
|April 25, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bortezomib Aqueous Solubility in the Presence and Absence of D-Mannitol: A Clarification With Formulation Implications.

Journal of pharmaceutical sciences·2020
Same author

Prodrugs: My Initial Exploration and Where It Led.

Journal of pharmaceutical sciences·2020
Same author

Sulfobutylether-β-cyclodextrin.

International journal of pharmaceutics·2020
Same author

Boric Acid, a Lewis Acid With Unique and Unusual Properties: Formulation Implications.

Journal of pharmaceutical sciences·2020
Same author

Some Preformulation Studies of Pyruvic Acid and Other α-Keto Carboxylic Acids in Aqueous Solution: Pharmaceutical Formulation Implications for These Peroxide Scavengers.

Journal of pharmaceutical sciences·2019
Same author

Origins, and formulation implications, of the pK<sub>a</sub> difference between boronic acids and their esters: A density functional theory study.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2018

Formulators can use the cyclodextrin utility number (U(CD)) to quickly assess if cyclodextrins are suitable solubilization enhancers for poorly water-soluble drugs, minimizing experimental effort.

Area of Science:

  • Pharmaceutical Sciences
  • Drug Delivery
  • Physical Chemistry

Background:

  • Poorly water-soluble drugs present significant formulation challenges.
  • Cyclodextrins are commonly used excipients to enhance drug solubility.
  • Predicting cyclodextrin efficacy requires efficient assessment tools.

Purpose of the Study:

  • To introduce a novel metric for evaluating cyclodextrin utility in drug formulations.
  • To provide a method for minimizing experimental screening of cyclodextrins.
  • To guide formulators in selecting appropriate cyclodextrins for poorly soluble drugs.

Main Methods:

  • Introduction of the cyclodextrin utility number, U(CD).
  • U(CD) incorporates drug dose, workable cyclodextrin amount, binding constant, and intrinsic drug solubility.

Related Experiment Videos

  • Extension of U(CD) to include ionizable drugs and synergistic solubility effects.

    • Main Results:

    • U(CD) provides a dimensionless number to assess cyclodextrin feasibility.
    • The metric is applicable to both neutral and ionizable poorly soluble drugs.
    • U(CD) serves as a guiding tool for formulators, not a definitive predictive model.

    Conclusions:

    • The cyclodextrin utility number (U(CD)) offers a practical approach to initial feasibility assessment.
    • This metric aids in efficient selection of cyclodextrins for drug solubilization.
    • U(CD) empowers formulators to make informed decisions with reduced experimentation.